ArticlePloS one2020

Risk-benefit analysis of isoniazid monotherapy to prevent tuberculosis in patients with rheumatic diseases exposed to prolonged, high-dose glucocorticoids.

Jun Won Park et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.